Tillis Calls for Action Against Pharmaceutical Companies That Limit Access to Discount Drugs for Vulnerable Communities
WASHINGTON, D.C. – Last week, U.S. Senator Thom Tillis (R-NC) and a bipartisan group of senators called for enforcement action to address practices of pharmaceutical companies that threaten to undermine the 340B Drug Pricing Program during the COVID-19 public health emergency. The 340B program